Chenliang Zhang

State Key Laboratory Of Biotherapy
Chengdu, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Synchronizing immunity with time: unlocking the potential of chrono-immunotherapy in cancer.

Synchronizing immunity with time: unlocking the potential of chrono-immunotherapy in cancer.

Journal: Frontiers in immunology

Published: May 21, 2026

Targeting the integrated stress response to overcome cancer therapy resistance: From mechanisms to therapeutic opportunities.

Targeting the integrated stress response to overcome cancer therapy resistance: From mechanisms to therapeutic opportunities.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: May 19, 2026

Factors Associated with Critical Thinking Disposition in Postgraduate Medical Students: A Cross-sectional Study.

Factors Associated with Critical Thinking Disposition in Postgraduate Medical Students: A Cross-sectional Study.

Journal: Journal of medical education and curricular development

Published: January 20, 2026

The Integrated Stress Response in Cancer: Paradox and Therapeutic Promise.

The Integrated Stress Response in Cancer: Paradox and Therapeutic Promise.

Journal: Comprehensive Physiology

Published: December 03, 2025

Accumulated sotorasib-bound KRASG12C reactivates the MAPK pathway and drives sotorasib resistance via the DHX9-RAC1-PAK1 axis.

Accumulated sotorasib-bound KRASG12C reactivates the MAPK pathway and drives sotorasib resistance via the DHX9-RAC1-PAK1 axis.

Journal: Cell reports

Published: November 18, 2025

The distinct roles of ROS in tumor immunity: from mechanisms to immunotherapeutic applications.

The distinct roles of ROS in tumor immunity: from mechanisms to immunotherapeutic applications.

Journal: Journal of hematology & oncology

Published: September 30, 2025

Targeting copper metabolic homeostasis to enable cuproptosis-based cancer therapy.

Targeting copper metabolic homeostasis to enable cuproptosis-based cancer therapy.

Journal: Chinese medical journal

Published: September 22, 2025

Targeting proteostasis for cancer therapy: current advances, challenges, and future perspectives.

Targeting proteostasis for cancer therapy: current advances, challenges, and future perspectives.

Journal: Molecular cancer

Published: July 15, 2025

Targeting pyroptosis for cancer immunotherapy: mechanistic insights and clinical perspectives.

Targeting pyroptosis for cancer immunotherapy: mechanistic insights and clinical perspectives.

Journal: Molecular cancer

Published: March 21, 2025

Nuclear p62/SQSTM1 facilitates ubiquitin-independent proteasomal degradation of BMAL1.

Nuclear p62/SQSTM1 facilitates ubiquitin-independent proteasomal degradation of BMAL1.

Journal: PLoS genetics

Published: March 05, 2025

Integrated multi-omics analysis revealed that SMARCAL1 serves as an immune related prognostic marker and promotes liver cancer growth via the Hippo/YAP signaling axis.

Integrated multi-omics analysis revealed that SMARCAL1 serves as an immune related prognostic marker and promotes liver cancer growth via the Hippo/YAP signaling axis.

Journal: International journal of surgery (London, England)

Published: January 29, 2025

Advancements in elucidating the mechanisms of Sorafenib resistance in hepatocellular carcinoma.

Advancements in elucidating the mechanisms of Sorafenib resistance in hepatocellular carcinoma.

Journal: International journal of surgery (London, England)

Published: November 14, 2024

Showing 1-12 of 29

Last Updated: 09/26/2026